BPC-157 10mg Research Material

Q: What is the intended use of this material?

It is supplied for laboratory research and analytical work only and is not intended for human or veterinary use.

Q: What analytical data appears on the certificate of analysis?

Displayed report #223088 lists BPC-157: 11.61mg and Purity: 99.635% for the submitted sample. Review the original laboratory record for the methods and results it actually contains. A published report does not by itself confirm the vial or lot shipped.

BPC-157 10 mg

$25.00

Research profileLab documentation

BPC-157 10 mg listing covering peptide sequence identity, HPLC purity documentation, lyophilized format, and cold storage handling notes. Research use only.

MaterialBPC-157 10 mg

Amount10mg per vial

FormLyophilized powder

Purity≥99% by HPLC · per-lot COA

StorageUnopened vial: store sealed, dry, and protected from light at controlled room temperature or refrigerated. After opening or reconstitution: keep refrigerated at 2–8 °C.

In stock · Fulfilled from Austin, TexasMost in-stock orders are usually processed within 1 business day after order review and payment approval.

CompoundBPC-157, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

CAS137525-51-0

Molecular formulaC62H98N16O22

Molecular weight1419.53 Da

Purity≥99% by HPLC · per-lot COA

Physical formLyophilized powder

Amount10mg per vial

StorageUnopened vial: store sealed, dry, and protected from light at controlled room temperature or refrigerated. After opening or reconstitution: keep refrigerated at 2–8 °C.

Current lot documentation

Submitted sample & third-party report

Review the current laboratory record and verify the task directly with the testing laboratory.

Verify on Janoshik

Janoshik submitted sample image for current lot — Submitted vial / sample

Third-party laboratory report for current lot — Laboratory report

LaboratoryJanoshik

Task#137569

Test dateApr 20, 2026

Measured content11.04mg

HPLC purity99.409%

BPC-157 is a synthetic pentadecapeptide of fifteen amino acid residues with the sequence GEPPPGKPADDAGLV. Its composition is dominated by a proline-rich N-terminal region and a pair of adjacent aspartate residues, and it contains no cysteine and therefore no disulfide bridge. It is produced by solid-phase peptide synthesis and supplied as the free-acid, non-acetylated form unless a lot certificate states otherwise.

No high-affinity receptor for BPC-157 has been established in the peer-reviewed literature, and no dissociation constant against a defined binding site has been reported. In-vitro characterisation is consequently framed around measured endpoints rather than a named target: reported systems include VEGFR2 phosphorylation quantified by immunoblot in cultured endothelial cell lines and nitric oxide synthase enzymatic assays in cell lysates. These are analytical readouts of a defined system and are reported as such.

Reference standard for HPLC and LC-MS method development and system-suitability checks
Gene- or protein-expression assays in cultured endothelial or fibroblast cell lines
Receptor phosphorylation immunoblotting in transfected or native cell lines
Enzymatic activity assays in cell lysates under defined cofactor conditions
Peptide stability and solubility characterisation under defined temperature and pH conditions
Amino acid analysis and sequence confirmation by tandem mass spectrometry

What is the intended use of this material?

How should the vial be stored before it is opened?

What analytical data appears on the certificate of analysis?

Your cart (items: 0)

Products in cart
Product	Details	Total
	Available on backorder Previous price: Discounted price:	Save